A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Clinical trial NCT07459647 · RECRUITING
Trial details
- NCT number
- NCT07459647
- Sponsor
- MapLight Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2030-02-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.